WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
$12,56
arrow_upward
+0,48%(+0,060) 1G
16 Eki, 16:00:00 GMT-4 · USD
search
Tüm semboller
| Sembol | Fiyat | Değişiklik | Değişiklik % |
|---|
insights_autoWXXWY ile ilgili en önemli analizler oluşturuluyor...
Açık
$12,29
Yüksek
$12,56
Düşük
$12,20
Piy. değ.
198,43 Mr
Ort. hacim
61,89 B
İşlem Hacmi
110,85 B
52 haftalık en yüksek
$14,80
52 haftalık en düşük
$7,30
Beta
0,01
Tedavüldeki hisse senedi sayısı
2,06 Mr
Çalışan sayısı
15 B
Açık
$12,29
Yüksek
$12,56
Düşük
$12,20
Piy. değ.
198,43 Mr
Ort. hacim
61,89 B
İşlem Hacmi
110,85 B
52 haftalık en yüksek
$14,80
52 haftalık en düşük
$7,30
Beta
0,01
Tedavüldeki hisse senedi sayısı
2,06 Mr
Çalışan sayısı
15 B
Haberler
Web kaynaklarından ve haber iş ortaklarından
The Motley Fool
·
49 dakika önce
A Record Number of S&P 500 Companies Issued Upbeat Guidance Before Earnings Season. Should You Buy an Index Fund Now?
MarketBeat
·
1 saat önce
Fox Corporation (NASDAQ:FOX) Stock Has Average Price Target of $76.56
Simply Wall Street
·
1 saat önce
What Pacira BioSciences Doubters Got Wrong
Yahoo Finance
·
22 saat önce
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Wuxi Biologics Cayman ADR hakkında
CEOZhisheng Chen
Çalışan Sayısı14,7 B
Kuruluş Tarihi2010
Genel Merkez-
Sektör-
Web Sitesiwuxibiologics.com